AvertD Test for First-Time Opioid Users
Part of Mental health clinical trials.
This study is testing a new tool called AvertD that helps doctors see if a patient might be at higher risk of developing opioid use disorder before they get their first opioid painkiller prescription. If you are getting your first opioid prescription for 4 to 30 days, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are about to receive your first-ever opioid prescription (for pain).
- Your prescription will be for 4 to 30 days.
- You are willing to take the AvertD test as part of your care.
- You can commit to yearly follow-up assessments for 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways of adjusting opioid use disorder treatment over time to find what works best for each person. It aims to improve recovery outcomes by adapting treatment based on individual progress.
This study tests a digital tool called Compl-AI that aims to predict whether someone with opioid use disorder might stop their medication early. If it works, doctors could step in sooner to help people stay on treatment.
This trial tests if a computer tool can help doctors prescribe medications for opioid use disorder during regular checkups. It may be right for you if you take prescription opioids for pain or have had issues with opioids.
This study tests a computer tool that helps doctors and patients safely reduce opioid pain medication. If you are tapering your opioid dose, the tool may help make the process smoother and safer.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
This trial is testing a tool to help people in the emergency department decide whether to start buprenorphine (a medication for opioid use disorder). It's for patients who are not already on medication for their condition.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.